In flow cytometry, the use of Annexin V has become one of the most widely adopted approaches for the analysis of cell death, particularly in the study of apoptosis. Its methodological basis, centered on the detection of phosphatidylserine externalization, has enabled for years a rapid and relatively reproducible readout of cellular viability states. However, advances in cell death biology have revealed a more complex reality: the exclusive use of Annexin V is not sufficient to reliably discriminate between different regulated cell death pathways.
The main limitation of relying solely on Annexin V is not technical but biological. Although phosphatidylserine externalization is a hallmark of early apoptosis, it is not exclusive to this pathway. There are multiple cellular contexts in which membrane lipid reorganization occurs without activation of a canonical apoptotic cascade. This introduces a significant bias in data interpretation, particularly in inflammatory systems or models where different forms of regulated cell death coexist.
In practice, Annexin V-based readouts tend to oversimplify a highly dynamic and heterogeneous biological process.
Apoptosis remains the most studied form of programmed cell death, characterized by caspase activation, chromatin condensation, and transient preservation of membrane integrity. In flow cytometry, researchers have extensively validated the classical identification of apoptosis using Annexin V/PI staining.
However, even within this framework, the transition from early to late apoptosis often overlaps with other cell death processes, which limits analytical resolution when researchers do not include additional functional markers.
Necroptosis represents a regulated form of cell death that challenges the classical apoptosis–necrosis dichotomy. It is dependent on the activation of RIPK1, RIPK3, and MLKL, ultimately leading to membrane rupture and release of intracellular content, with a strong inflammatory component.
From a cytometric perspective, necroptosis is particularly challenging because its phenotypic profile can overlap with late apoptosis in Annexin V/PI assays. Without specific pathway markers such as MLKL phosphorylation or signaling intermediates, researchers can only identify it with very limited accuracy.
Pyroptosis adds another layer of complexity to cell death analysis. It is a highly inflammatory process mediated by inflammasome activation and inflammatory caspases such as caspase-1, caspase-4, and caspase-5, leading to pore formation in the plasma membrane via gasdermin proteins.
This process results not only in rapid loss of membrane integrity but also in the release of pro-inflammatory cytokines such as IL-1β and IL-18. In flow cytometry, its signature can be mistaken for late-stage cell death unless specific readouts of caspase activity or inflammatory signaling are included.
The classical Annexin V and propidium iodide (PI) staining scheme remains widely used to classify cells as viable, early apoptotic, late apoptotic, or necrotic. However, this model shows clear limitations when applied to complex biological systems.
Its main weakness lies in its inability to distinguish between secondary necrosis, necroptosis, and late apoptosis, as well as its complete lack of resolution for inflammatory cell death processes such as pyroptosis. As a result, apoptosis may be overestimated, while alternative death pathways remain underrepresented.
The increasing complexity of cell death research has driven the adoption of multiparametric flow cytometry strategies. These approaches integrate not only membrane integrity markers but also enzymatic activity probes, pathway-specific signaling proteins, and inflammatory readouts.
Incorporating measurements related to active caspases, RIPK/MLKL signaling components, and inflammatory mediators provides a far more accurate resolution of distinct cell death programs, reducing the ambiguity inherent to classical assays.
Although Annexin V remains a fundamental tool in cell viability analysis, its standalone use is insufficient to capture the complexity of modern cell death biology. Distinguishing between apoptosis, necroptosis, and pyroptosis requires a more integrated approach based on multiple functional parameters.
Only through this multiparametric strategy is it possible to faithfully translate biological complexity into cytometric readouts, avoiding oversimplified interpretations that may compromise the depth and accuracy of experimental analysis.